Patients are our priority and at the heart of our work here at Sandoz. Each day, we work together to help create a healthier world in which everyone has access to the medicines they need, no matter who or where they are.
Tuberculosis, commonly known as TB is curable and preventable disease; yet every minute, someone is infected with TB. Early detection and taking full course of treatment with standardized anti- TB drugs can help cure TB.
SPRITUS, the in-house scientific journal developed by Sandoz provides the contemporary information in the area of tuberculosis to TB physicians. SPIRITUS contains scientific updates from WHO and other organizations, published and contributed articles by TB experts around the world.
From 2005 to 2012, Novartis has donated nearly 500,000 TB treatments to Tanzania. This donation is made available through the Global Drug Facility (GDF) of the Stop TB Partnership, which is hosted by the World Health Organization.
Sandoz is a WHO prequalified manufacturer of anti- TB drugs. Sandoz supplies its high quality anti- TB drugs to WHO and other National TB programmes from its state of the art dedicated manufacturing capacities for Rifampicin based formulations based in in India.